Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test
Clinical trial NCT04221906 · COMPLETED
Trial details
- NCT number
- NCT04221906
- Sponsor
- Boston Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-06
- Primary completion
- 2020-03-06
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.